Northwell Health | Strategic Alliance Partners

Northwell Health Cancer Institute seamlessly integrates Northwell’s world-class hospitals, innovative treatments and leading cancer specialists of every kind. We’re dedicated to cancer prevention, screening, diagnosis, treatment, research and survivorship. Our disease-focused, multidisciplinary teams provide holistic care, treating patients’ cancer, as well as working with colleagues in disciplines throughout Northwell to treat any other existing medical conditions. Our experts provide comprehensive, compassionate care through innovative clinical trials, state-of-the-art medical and radiation oncology treatments and leading edge surgical techniques. More New Yorkers choose Northwell for cancer care than any other health system —which means you have access to the most experienced cancer fighters in the state.

Latest from Northwell Health


Dr. Barrientos on Remaining Challenges in CLL

May 24, 2019

Jacqueline C. Barrientos, MD, associate professor, The Feinstein Institute for Medical Research, Northwell Health, discusses remaining challenges in the treatment of patients with chronic lymphocytic leukemia.

Dr. Barrientos Discusses Promising Agents in CLL

April 01, 2019

Jacqueline C. Barrientos, MD, associate professor, The Feinstein Institute for Medical Research, Northwell Health, discusses promising agents in the treatment of patients with chronic lymphocytic leukemia.

Grant Studies Female Fertility App for Cancer Survivors

September 26, 2018

Feinstein Institute for Medical Research Assistant Professor Catherine Benedict, PhD, has been awarded a 5-year, $693,000 grant from the National Institutes of Health to develop and test a digital health platform to help young female cancer survivors evaluate their options for having children, make decisions and plan for the future.

Prostate Biopsy Procedure Eliminates Risk of Infection

September 26, 2018

Urologists at Northwell Health’s Smith Institute for Urology recently started offering a new biopsy procedure which samples tissue from the prostate to potentially detect cancer – and eliminates the risk of infection.

Rai Helped Launch an Age of Innovation in Leukemia

August 05, 2018

Kanti R. Rai, MD, has been a leader in the diagnosis and treatment of chronic lymphocytic leukemia for more than 40 years. He was honored in the Hematologic Malignancies category with a 2017 Giants of Cancer Care® award.

Dr. Barrientos Discusses Acalabrutinib in CLL

March 29, 2018

Jacqueline C. Barrientos, MD, associate professor, The Feinstein Institute for Medical Research, Northwell Health, discusses the role of acalabrutinib (Calquence) for patients with chronic lymphocytic leukemia (CLL).

Dr. Barrientos on the Impact of Combinations in CLL

March 15, 2018

Jacqueline C. Barrientos, MD, associate professor, The Feinstein Institute for Medical Research, Northwell Health, discusses the impact of combinations in the treatment of chronic lymphocytic leukemia.

Dr. Barrientos Discusses Combination Strategies in CLL

February 20, 2018

Jacqueline C. Barrientos, MD, associate professor, The Feinstein Institute for Medical Research, Northwell Health, discusses the impact of recent combination trials for patients with chronic lymphocytic leukemia (CLL).

Dr. Barrientos on the Role of Acalabrutinib in CLL

January 26, 2018

Jacqueline C. Barrientos, MD, associate professor, The Feinstein Institute for Medical Research, Northwell Health, discusses the role of acalabrutinib (Calquence) for patients with chronic lymphocytic leukemia (CLL).